GAD1 and encephalomyelitis: An experimental study reported CNS destruction with lethal encephalomyelitis-like disease mediated by GAD-specific CD4+ T cells; conversely, the effect of B-cell-generated high titer anti-GAD65 autoantibodies had no effect on the incidence or severity of disease (Burton et al., 2010).